DIPROSALIC OINTMENT
Țară: Singapore
Limbă: engleză
Sursă: HSA (Health Sciences Authority)
Prospect
(PIL)
18-02-2013
Unele documente pentru acest produs nu sunt disponibile în prezent, puteți trimite o solicitare la serviciul nostru pentru clienți și vă vom anunța de îndată ce vom putea să le obținem.
Trimite cerere.
Trimite cerere.
Ingredient activ:
BETAMETHASONE DIPROPIONATE 0.64MG/G EQV BETAMETHASONE
Disponibil de la:
MSD PHARMA (SINGAPORE) PTE. LTD.
Codul ATC:
D07XC01
Dozare:
0.50 mg/g
Forma farmaceutică:
OINTMENT
Calea de administrare:
TOPICAL
Tip de prescriptie medicala:
Prescription Only
Produs de:
S-P CANADA
Data de autorizare:
1990-04-20
Prospect
DIPROSALIC® OINTMENT
Brand of betamethasone dipropionate and salicylic acid
FOR DERMATOLOGIC USE ONLY
DESCRIPTION: DIPROSALIC Ointment provides in each gram 0.64
mg of betamethasone
dipropionate, equivalent to 0.5 mg (0.05%) of betamethasone, and
30 mg (3%) of salicylic acid.
Salicylic acid is a keratolytic and antiseptic agent.
ACTIONS: Betamethasone dipropionate, a synthetic fluorinated corticosteroid, has anti-
inflammatory, antipruritic and
vasoconstrictive actions. DIPROSALIC Ointment demonstrates these
actions in a sustained
manner thereby permitting twice a day application.
Topical salicylic acid has keratolytic properties as well as
bacteriostatic and fungicidal actions.
INDICATIONS AND USAGE: DIPROSALIC Ointment
is indicated for the relief of the inflammatory
manifestations of hyperkeratotic and
dry corticosteroidresponsive dermatoses such as: psoriasis,
chronic atopic dermatitis, neurodermatitis
(lichen simplex chronicus), lichen planus, eczema
(including nummular eczema, hand eczema, eczematous dermatitis),
dyshidrosis (pompholyx),
seborrheic dermatitis of the scalp, ichthyosis vulgaris and
other ichthyotic conditions.
DOSAGE AND
ADMINISTRATION: A thin film of DIPROSALIC Ointment should
be applied to
cover completely the affected area, twice daily,
in the morning and at night. For some patients,
adequate maintenance therapy may be achieved with less
frequent application.
ADVERSE REACTIONS: Adverse reactions that have been reported with
the use of topical
corticosteroids include: burning, itching, irritation, dryness,
folliculitis, hypertrichosis, acneiform
eruptions, hypopigmentation, perioral dermatitis, allergic
contact dermatitis.
The following may occur more frequently with the use of occlusive dressings: maceration of the skin,
secondary infection, skin atrophy, striae and mil
Citiți documentul complet
